ENTITY
Shanghai Haohai Biological Technology

Shanghai Haohai Biological Technology (6826 HK)

136
Analysis
Health Care • China
Shanghai Haohai Biological Technology engages in the research, development, manufacture, and sale of biomedical materials and pharmaceutical products. The company focuses on therapeutic areas including ophthalmology, medical aesthetics and wound care, orthopedics, and anti-adhesion and hemostasis, with key products such as intraocular lenses, hyaluronic acid dermal fillers, and sodium hyaluronate injections. It is headquartered in Shanghai, China, and was founded in 2007.
more
•05 Dec 2022 08:30

A-H Premium Weekly (Dec 2nd): China Longyuan, Ganfeng Lithium

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Longyuan, Ganfeng Lithium, Shanghai Fudan, Red Star...

Logo
473 Views
Share
•20 Nov 2022 11:28

A-H Premium Weekly (Nov 18th): China Longyuan, GF Securities, Great Wall Motor

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Longyuan, GF Securities, Great Wall Motor, COSCO...

Logo
447 Views
Share
•13 Nov 2022 11:57

A-H Premium Weekly (Nov 11th): BYD, Dongfang Electric, Pharmaron Beijing, CSC Financial

We analyzed A-H premium changes in the past week and highlight A-H premium changes for BYD, Dongfang Electric, Pharmaron Beijing, CSC Financial.

Logo
512 Views
Share
•01 Nov 2022 12:06

Hong Kong Connect Flows Monthly: $8.1bn Inflows in October

We analyzed the Hong Kong Connect Scheme for October and highlight flows for Tencent, Meituan, Wuxi Biologics, Li Auto, Kuaishou, Tsingtao Brewery.

Logo
366 Views
Share
•30 Oct 2022 10:03

Hong Kong Connect Flows (Oct 28th): Tencent, Meituan, Wuxi Biologics, Kuaishou

We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, Meituan, Wuxi Biologics, Kuaishou.

Logo
411 Views
Share
x